Let me do more than count the ways: What circulating tumor cells can tell us about the biology of cancer

Molecular Pharmaceutics

Volumn 6, Issue 5, 2009, Pages 1307-1310

  Budd, G Thomas ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Circulating tumor cells; Disseminated tumor cells; Predictive factors; Prognostic factors

Indexed keywords

BIOLOGICAL MARKER;

ADVANCED CANCER; CANCER CELL; CELL COUNT; CONFERENCE PAPER; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; METASTASIS; PERIPHERAL CIRCULATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARDIZATION; TREATMENT OUTCOME;

CELL COUNT; HUMANS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS;

EID: 70350042015     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp900088r     Document Type: Conference Paper

References (26)

1. Ashworth, T. R. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust. Med J. 1869, 14, 146.
2. Ross, A. A.; Cooper, B. W.; Lazarus, H. M.; Mackay, W.; Moss, T. J.; Ciobanu, N.; et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993, 82 (9), 2605-2610
3. Yang, L.; Lang, J. C.; Balasubramanian, P.; Jatana, K. R.; Schuller, D.; Agrawal, A.; et al. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol. Bioeng. 2009, 102 (2), 521-534
4. Allard, W. J.; Matera, J.; Miller, M. C.; Repollet, M.; Connelly, M. C.; Rao, C.; et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 2004, 10 (20), 6897-6904
5. Stathopoulou, A.; Angelopoulou, K.; Perraki, M.; Georgoulias, V.; Malamos, N.; Lianidou, E. Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer. Clin Biochem. 2001, 34 (8), 651-659 (Pubitemid 34159357)
6. Ignatiadis, M.; Xenidis, N.; Perraki, M.; Apostolaki, S.; Politaki, E.; Kafousi, M.; et al. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. J. Clin. Oncol. 2007, 25 (33), 5194-5202
7. Nagrath, S.; Sequist, L. V.; Maheswaran, S.; Bell, D. W.; Irimia, D.; Ulkus, L.; et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450 (7173), 1235-1239
8. Maheswaran, S.; Sequist, L. V.; Nagrath, S.; Ulkus, L.; Brannigan, B.; Collura, C. V.; et al. Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med. 2008, 359 (4), 366-377
9. Fehm, T.; Muller, V.; Alix-Panabieres, C.; Pantel, K. Micrometastatic spread in breast cancer: Detection, molecular characterization and clinical relevance. Breast Cancer Res. 2008, 10 (Suppl. 1), S1.
10. Alix-Panabieres, C.; Rebillard, X.; Brouillet, J. P.; Barbotte, E.; Iborra, F.; Segui, B.; et al. Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients. Clin. Chem. 2005, 51 (8), 1538-1541 (Pubitemid 41060898)
11. Schwarzenbach, H.; Alix-Panabieres, C.; Muller, I.; Letang, N.; Vendrell, J. P.; Rebillard, X.; et al. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin. Cancer Res. 2009, 15 (3), 1032-1038
12. Zheng, S.; Lin, H.; Liu, J. Q.; Balic, M.; Datar, R.; Cote, R. J.; et al. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J. Chromatogr. A 2007, 1162 (2), 154-161
13. Fehm, T.; Sagalowsky, A.; Clifford, E.; Beitsch, P.; Saboorian, H.; Euhus, D.; et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res. 2002, 8 (7), 2073-2084
14. Fehm, T.; Morrison, L.; Saboorian, H.; Hynan, L.; Tucker, T.; Uhr, J. Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors. Breast Cancer Res. Treat. 2002, 75 (3), 227-239 (Pubitemid 35026116)
15. Cristofanilli, M.; Budd, G. T.; Ellis, M. J.; Stopeck, A.; Matera, J.; Miller, M. C.; et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 2004, 351 (8), 781-791 (Pubitemid 39095313)
16. de Bono, J. S.; Scher, H. I.; Montgomery, R. B.; Parker, C.; Miller, M. C.; Tissing, H.; et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 2008, 14 (19), 6302-6309
17. Cohen, S. J.; Punt, C. J.; Iannotti, N.; Saidman, B. H.; Sabbath, K. D.; Gabrail, N. Y.; et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 2008, 26 (19), 3213-3221
18. Hayes, D. F.; Cristofanilli, M.; Budd, G. T.; Ellis, M. J.; Stopeck, A.; Miller, M. C.; et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin. Cancer Res. 2006, 12 (14 Part 1), 4218-4224
19. Liu, M. C.; Shields, P.; Isaacs, C.; Warren, R.; Cohen, P.; Wilkinson, M.; et al. Circulating tumor cells (CTC): Assessment of treatment efficacy in metastatic breast cancer (MBC). J. Clin. Oncol. 2007, 25 (18S), 10535.
20. Liu, M. C.; Isaacs, C.; Warren, R.; Cohen, P.; Wilkinson, M.; Ottaviano, Y.; et al. Circulating tumor cells (CTC): A reliable predictor of treatment efficacy in metastatic breast cancer (MBC). J. Clin. Oncol. 2008, 26, 11018.
21. Budd, G. T.; Cristofanilli, M.; Ellis, M. J.; Stopeck, A.; Borden, E.; Miller, M. C.; et al. Circulating tumor cells versus imaging - predicting overall survival in metastatic breast cancer. Clin. Cancer Res. 2006, 12 (21), 6403-6409 (Pubitemid 44799711)
22. De Giorgi, U.; Valero, V.; Rohren, E.; Dawood, S.; Ueno, N. T.; Miller, M. C.; et al. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J. Clin. Oncol. 2009, 27 (20), 3303-3311
23. Hayes, D. F.; Walker, T. M.; Singh, B.; Vitetta, E. S.; Uhr, J. W.; Gross, S.; et al. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int. J. Oncol. 2002, 21 (5), 1111-1117
24. Fehm, T.; Becker, S.; Duerr-Stoerzer, S.; Sotlar, K.; Mueller, V.; Wallwiener, D.; et al. Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status. Breast Cancer Res. 2007, 9 (5), R74.
25. Rack, B. K.; Schindlbeck, C.; Schneeweiss, A.; Hilfrich, J.; Lorenz, R.; Beckmann, M. W.; et al. In Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy: The German SUCCESS-trial; 2008 ASCO annual meeting; May 20, 2008.
26. Pachmann, K.; Camara, O.; Kavallaris, A.; Krauspe, S.; Malarski, N.; Gajda, M.; et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J. Clin. Oncol. 2008, 26 (8), 1208-1215